BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5289024)

  • 1. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor.
    Levin AS; Spitler LE; Stites DP; Fudenberg HH
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):821-8. PubMed ID: 5289024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Wiskott-Aldrich syndrome. Results of transfer factor therapy.
    Spitler LE; Levin AS; Stites DP; Fudenberg HH; Pirofsky B; August CS; Stiehm ER; Hitzig WH; Gatti RA
    J Clin Invest; 1972 Dec; 51(12):3216-24. PubMed ID: 4640955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer factor therapy in immuno-deficiencies.
    Griscelli C; Revillard JP; Betuel H; Herzog C; Touraine JL
    Biomedicine; 1973 May; 18(3):220-7. PubMed ID: 4742861
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses of transfer factor.
    Basten A; Croft S; Kenny DF; Nelson DS
    Vox Sang; 1975; 28(4):257-77. PubMed ID: 804764
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of the transfer factor].
    Mutz I; Humphrey GB
    Wien Klin Wochenschr; 1973 May; 85(20):357-60. PubMed ID: 4574399
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of transfer factor therapy on mixed lymphocyte culture reactivity.
    Dupont B; Ballow M; Hansen JA; Quick C; Yunis EJ; Good RA
    Proc Natl Acad Sci U S A; 1974 Mar; 71(3):867-71. PubMed ID: 4274562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor.
    Ballow M; Dupont B; Good RA
    J Pediatr; 1973 Nov; 83(5):772-80. PubMed ID: 4742570
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic and clinical implications of transfer factor.
    Mutz I; Lankford J; Humphrey GB
    South Med J; 1974 Jul; 67(7):837-40. PubMed ID: 4599982
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfer factor.
    Good RA
    Cell Immunol; 1972 Apr; 3(4):i-iv. PubMed ID: 4554090
    [No Abstract]   [Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor.
    Sellars WA; South MA
    Am J Dis Child; 1975 May; 129(5):622-7. PubMed ID: 806224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transfer factor and its therapeutic use].
    Rosenthal M
    Schweiz Med Wochenschr; 1974 Oct; 104(43):1501-6. PubMed ID: 4549135
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity.
    Valentine FT; Lawrence HS
    Adv Intern Med; 1971; 17():51-93. PubMed ID: 4147307
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor therapy in immunodeficiency.
    Griscelli C
    Birth Defects Orig Artic Ser; 1975; 11(1):462-4. PubMed ID: 1148388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosette-forming cells, immunologic deficiency diseases and transfer factor.
    Wybran J; Levin AS; Spitler LE; Fudenberg HH
    N Engl J Med; 1973 Apr; 288(14):710-3. PubMed ID: 4540063
    [No Abstract]   [Full Text] [Related]  

  • 20. Phytohemagglutinin as a skin test for the evaluation of cellular immune competence in man.
    Blaese RM; Weiden P; Oppenheim JJ; Waldmann TA
    J Lab Clin Med; 1973 Apr; 81(4):538-48. PubMed ID: 4696186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.